NOOSPHERE

Public document records

Bibliographic records with public provenance and stable links. The catalog does not include all documents in the corpus or reproduce their full texts.

98,186 public records · page 334 / 982

  1. Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity.2022 · PubMed
  2. Narcissism and the Lure of Grandiosity Over Reality: Reflections on a Narcissistic Inhibition in Creativity2022 · Crossref
  3. Narrative Review of Kratom, an Emerging Psychoactive Substance With Perianesthetic Implications2022 · Crossref
  4. Narrative therapy in psychedelic harm reduction: Supporting safety, agency and meaning-making2022 · Crossref
  5. Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment2022 · Crossref
  6. National Academy of Medicine on stigma, calls for ‘people‐first’ approach2022 · Crossref
  7. Nationwide Survey of Trauma Center Screening and Intervention Practices for Posttraumatic Stress Disorder, Firearm Violence, Mental Health, and Substance Use Disorders2022 · Crossref
  8. Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID ‐192022 · Crossref
  9. Natural Hallucinogens in Mental Health2022 · OpenAlex
  10. Natural Products for the Treatment of Drug Addiction: Narrative Review2022 · Crossref
  11. Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.2022 · PubMed
  12. Natural Sympathomimetic Drugs: From Pharmacology to Toxicology2022 · OpenAlex
  13. Naturalistic Entheogenics2022 · OpenAlex
  14. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences2022 · OpenAlex
  15. Nature of human intelligence2022 · OpenAlex
  16. Navigating conflicting value systems: a grounded theory of the process of public health equity work in the context of mental health promotion and prevention of harms of substance use2022 · OpenAlex
  17. Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic2022 · Crossref
  18. Navigating Opioid Agonist Therapy among Young People who use Illicit Opioids in Vancouver, Canada2022 · OpenAlex
  19. Navigating social interactions and constructing vaping social identities: A qualitative exploration with New Zealand young adults who smoke2022 · Crossref
  20. Navigating the grey: Experiences of incremental cannabis reform in Australia2022 · Crossref
  21. Navigating the LGB Data Landscape: A Review of Appropriate Secondary Data Sources for Sexuality and Substance Use Research in the UK2022 · OpenAlex
  22. Near-infrared spectroscopy as a green technology to monitor coffee roasting2022 · Crossref
  23. Need for Clarity and Context in Case Reports on Kratom Use, Assessment, and Intervention2022 · Crossref
  24. Need for comprehensive and timely data to address the opioid overdose epidemic without a blindfold2022 · OpenAlex
  25. Needle exchange practitioners accounts of delivering harm reduction advice for chemsex: implications for policy and practice2022 · OpenAlex
  26. Needs and experiences of people practising chemsex with support services: toward chemsex-affirmative interventions2022 · OpenAlex
  27. Needs of Patients with Opioid Dependence: Are the Perspectives of Substance Use Disorder – Patients and their Family Caregivers Similar?2022 · Crossref
  28. Negative attitudes about medications for opioid use disorder among criminal legal staff2022 · OpenAlex
  29. Negative but Not Positive Alcohol-Related Consequences Tend to Occur Above the Heavy Episodic Drinking Threshold: A Daily Study of Young Adult Heavy Drinkers2022 · Crossref
  30. Negative experiences, social exclusion and unwanted attention on social media: exploring the association with adolescent alcohol use2022 · Crossref
  31. Negotiating Ambiguous Substance Use: UK newspaper representations of self-prescribing medicinal cannabis use in the 1990s2022 · Crossref
  32. Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment2022 · Crossref
  33. Neural mechanisms of psychedelic visual imagery2022 · OpenAlex
  34. Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.2022 · PubMed
  35. Neural substrates of substance use disorders2022 · Crossref
  36. Neurobiological Basis of Aversion-Resistant Ethanol Seeking in C. elegans2022 · Crossref
  37. Neurobiological foundations of the formation of behavior and use of psychoactive substances among adolescents (literature review)2022 · Crossref
  38. Neurobiological mechanisms and related clinical treatment of addiction: a review2022 · OpenAlex
  39. Neurobiological Mechanisms of Nicotine Reward and Aversion2022 · OpenAlex
  40. Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation?2022 · OpenAlex
  41. Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication2022 · Crossref
  42. Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study2022 · Crossref
  43. Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine2022 · OpenAlex
  44. Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments.2022 · PubMed
  45. Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities2022 · OpenAlex
  46. Neurology of Religious Experiences2022 · OpenAlex
  47. Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin2022 · OpenAlex
  48. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders2022 · OpenAlex
  49. Neuroprotective effect of Achillea millefolium aqueous extract against oxidative stress and apoptosis induced by chronic morphine in rat hippocampal CA1 neurons2022 · Crossref
  50. Neuroprotective Effect of Caffeine in Alzheimer’s Disease2022 · OpenAlex
  51. Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimer’s Disease2022 · Crossref
  52. Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans2022 · Crossref
  53. Neuropsychological effect on long-term Ayahuasca use2022 · OpenAlex
  54. Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP (“flakka”) Derivatives2022 · OpenAlex
  55. Neurosurgery in the Treatment of Alcohol Use Disorder: A Systematic Literature Review2022 · Crossref
  56. Neurotoxicity of pesticides – A link to neurodegeneration2022 · OpenAlex
  57. Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe2022 · OpenAlex
  58. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine2022 · OpenAlex
  59. Neuro‐plastic Shamanism? Towards a Political Ontology of Whiteness and the Psychedelic Zeitgeist2022 · OpenAlex
  60. Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge2022 · Crossref
  61. Neutrosophic cognitive maps for analysis of social problems analysis2022 · Crossref
  62. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts2022 · Crossref
  63. New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression2022 · OpenAlex
  64. New center to take personalized care to next level, embracing psychedelics2022 · Crossref
  65. New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction2022 · Crossref
  66. New cup out of old coffee: contribution of parental gene expression legacy to phenotypic novelty in coffee beans of the allopolyploid Coffea arabica L.2022 · Crossref
  67. New drug policy organization to focus on bold moves2022 · Crossref
  68. New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders2022 · OpenAlex
  69. New indicators of health among adolescent drug users and evaluation of drug policies comparing countries2022 · Crossref
  70. New indicators of illegal drug use to compare drug user populations for policy evaluation2022 · Crossref
  71. New Insight into Ornamental Applications of Cannabis: Perspectives and Challenges2022 · OpenAlex
  72. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders2022 · OpenAlex
  73. New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances2022 · Crossref
  74. New Kinds of [Hash]tags2022 · OpenAlex
  75. New Naloxone Concentration Treats Opioid Overdose2022 · Crossref
  76. New Paradigms of Old Psychedelics in Schizophrenia2022 · Crossref
  77. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?2022 · OpenAlex
  78. New Psychoactive Substances Consumption in Opioid-Use Disorder Patients2022 · OpenAlex
  79. New Psychoactive Substances: Awareness and Attitudes of Future Health Care Professionals in Serbia2022 · OpenAlex
  80. New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?2022 · OpenAlex
  81. New study shows fathers are accused by family court when pregnant partners use substances2022 · Crossref
  82. New Synthetic Opioids Use among Patients in Treatment for an Opioid Use Disorder in Barcelona2022 · OpenAlex
  83. New terbium complex as a luminescent probe for determination of chlorogenic acid in green coffee and roasted coffee infusions2022 · Crossref
  84. Next generation genetically encoded fluorescent sensors for serotonin2022 · OpenAlex
  85. NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service program2022 · OpenAlex
  86. NIAAA updates “Rethinking Drinking” booklet and website2022 · Crossref
  87. Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases2022 · Crossref
  88. Nicotine Addiction and Intensity of e-Cigarette Use by Adolescents in the US, 2014 to 20212022 · OpenAlex
  89. Nicotine in Inflammatory Diseases: Anti-Inflammatory and Pro-Inflammatory Effects2022 · OpenAlex
  90. Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users2022 · Crossref
  91. NIDA details research on treatments for methamphetamine use disorder2022 · Crossref
  92. Nightlife and COVID Vaccinations2022 · Crossref
  93. NIRS and Aquaphotomics Trace Robusta-to-Arabica Ratio in Liquid Coffee Blends2022 · OpenAlex
  94. Nitrogen Source Matters: High NH4/NO3 Ratio Reduces Cannabinoids, Terpenoids, and Yield in Medical Cannabis2022 · OpenAlex
  95. Nitrous Oxide in Treatment Resistant Major Depression: Should We Laugh About It?2022 · OpenAlex
  96. Nitrous oxide-induced myeloneuropathy: an emerging public health issue2022 · OpenAlex
  97. Nitrous oxide–induced reproductive risks: Should recreational nitrous oxide users worry?2022 · OpenAlex
  98. NMDA and P2X7 Receptors Require Pannexin 1 Activation to Initiate and Maintain Nociceptive Signaling in the Spinal Cord of Neuropathic Rats2022 · OpenAlex
  99. NMR Spectroscopy Applied to the Metabolic Analysis of Natural Extracts of Cannabis sativa2022 · Crossref
  100. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis2022 · OpenAlex